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Abstract
Background: Access to most contraceptives in Australia requires a prescription from a doctor, and it has been
shown that doctors can influence women’s decision-making with respect to contraception. However, little research has
documented how women experience their interactions with doctors within the context of a contraceptive consultation.
Understanding such experiences may contribute to our knowledge of factors that may influence women’s contraceptive
decisions more broadly.
Methods: We report on findings from the Contraceptive Use, Pregnancy Intentions and Decisions (CUPID) survey
of young Australian women, a large-scale longitudinal study of 3,795 women aged 18–23 years. We performed a
computer-assisted search for occurrences of words that indicated an interaction within the 1,038 responses to an
open-ended question about contraception and pregnancy. We then applied a combination of conventional and
summative content analysis techniques to the 158 comments where women mentioned an interaction about
contraception with a doctor.
Results: Our analysis showed that women desire consistent and accurate contraception information from
doctors, in addition to information about options other than the oral contraceptive pill. Some young women reported
frustrations about the choice limitations imposed by doctors, perceived by these women to be due to their young age.
Several women expressed disappointment that their doctor did not fully discuss the potential side-effects of
contraceptives with them, and that doctors made assumptions about the woman’s reasons for seeking contraception.
Some women described discomfort in having contraception-related discussions, and some perceived their doctor to
be unsupportive or judgmental.
Conclusions: Both the content and the process of a contraceptive consultation are important to young Australian
women, and may be relevant contributors to their choice and ongoing use of a contraceptive method. These
findings provide useful insights into aspects of the patient-provider interaction that will enhance the efficacy of
the contraceptive consultation. It is recommended that doctors adopt patient-centred, shared decision-making
strategies to support women in making choices about contraception that suit their individual circumstances. We
also acknowledge the need to involve other health care providers, other than doctors, in educating, informing,
and assisting women to make the best contraceptive choice for themselves.
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Background
Most sexually active Australian women of reproductive
age who want to avoid pregnancy use contraception [1].
Several forms of hormonal and non-hormonal contra-
ception are available: condoms, the diaphragm, the oral
contraceptive pill (OCP), the vaginal ring, long-acting
reversible contraception (LARC) options including im-
plant, injection, and intrauterine methods, as well as
the over-the-counter levonorgestrel emergency contra-
ceptive (LNG-EC) pill [2]. Short-acting methods such
as the OCP have lower effectiveness than LARC [3, 4];
yet despite the availability of numerous, highly effective
LARC methods and recent clinical recommendations
encouraging the uptake of such options [5, 6], the most
common contraceptive method used by young Australian
women remains the OCP [7–9]. While the OCP is effective,
many women find it difficult to use consistently, which
leads to high discontinuation rates [10]. In addition, there is
a high rate of induced abortion in Australia [11], suggesting
that contraception non-use, ineffective use, and failure
remains a significant problem. Previous research has
highlighted that although both women and men ac-
knowledge the need for contraception to prevent un-
intended pregnancy, they generally lack knowledge
about the range of methods available to them and how
to use their preferred method correctly [12].
Aside from the condom, LNG-EC pill, and fertility
awareness-based methods (i.e. diaphragms, withdrawal,
and natural family planning), access to other contraception
methods in Australia necessitates a doctor’s prescription,
obtained most commonly through consulting a general
practitioner or family planning clinic. Doctors working
in such settings therefore typically represent the first
point-of-contact for young people seeking sexual health
and contraceptive advice and may have a substantial
influence on young women’s decision-making with respect
to contraception. Indeed, a US cohort study of 1,387
women aged 15–24 years who were starting a hormonal
contraceptive found that despite the majority of partici-
pants reporting that they had selected their chosen
method for themselves, over half also reported that they
selected the method because of what their healthcare
provider had told (or had not told) them [13]. Compar-
ably, a qualitative investigation of young women’s contra-
ceptive choices before and after seeing a provider at a
family planning clinic found that just under a quarter of
participants who reported not desiring a hormonal or
LARC method prior to the interaction ultimately selected
such a method after discussing LARC methods with the
provider [14].
Best practice in contraceptive care across several
countries including Australia, the UK, and the US has
moved away from a doctor-centred model of care toward a
patient-centred care model, which conceptualises patients
as consumers who are informed and engaged when making
decisions about their own health [15]. To make good deci-
sions about their own health however, patients need to have
access to reliable, comprehensive information [16]. To
make good decisions about contraception, women must be
aware of the available options and be able to weigh up the
benefits and disadvantages of various methods for their
own particular situation. Shared decision-making, a core
component of the patient-centred model of care, requires
the woman and doctor to reach a shared understanding of
the woman’s situation and preferences [17]. In the process
of shared decision-making, the clinician’s role is “to help
patients become well-informed, help them develop their
personal preferences for available options, and provide
professional guidance where appropriate” ([18], p. 271).
As this ‘position description’ suggests, the issue is not
as simple as providing accurate information in a unidirec-
tional manner; the clinician also has to interpret informa-
tion that the patient provides and deliver advice within a
bidirectional interactional system. Recent research suggests
that women are more likely to contribute to decisions
about contraception than they are about their general
healthcare [19], with contraceptive consultations found
to be most effective when the woman’s concerns are
correctly understood and addressed by the clinician [20].
Through documenting the decisions that women make
following a contraceptive consultation, the literature
reviewed above evidences that healthcare providers-
particularly doctors- can influence a woman’s contra-
ceptive choices. In order to understand the factors that
may influence these choices more broadly, it is also im-
portant to appreciate women’s interactional experiences
with a doctor in the context of a contraceptive consult-
ation. For example, an interview-based qualitative study
of women’s perceptions of the contraception consult-
ation in the UK found that women felt judged on social
as opposed to medical grounds when consulting doc-
tors about contraception, with doctors routinely dis-
missing or disregarding women’s reports of adverse
side-effects [21]. Women’s subsequent contraceptive
choices were evidently influenced by these interactions,
as well as their trust in the healthcare provider. Further-
more, a recent Australian study exploring how women ob-
tain and use contraception (and the barriers to doing so)
found that young women reported dissatisfaction with the
amount of information doctors provide about contracep-
tion in addition to negative interactions with healthcare
providers when accessing contraception [22].
In order to understand what young (Australian) women
want- and do not want- when interacting with a doctor in
the context of a contraceptive consultation, we specifically
aim here to qualitatively document how women perceive
and report on their interactions with a doctor about contra-
ception. Such findings contribute to the broader question
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of what factors may influence the decisions women make
about contraception use and method choice. Throughout
this paper, the term ‘doctor’ is used to refer to a doctor of
any speciality who provides contraceptive care to women,
and is not limited to describing general practitioners.
Methods
Study design and participants
The data we report on here were drawn from the 3,795
women who responded to the Contraceptive Use, Preg-
nancy Intentions and Decisions (CUPID) study; a longitu-
dinal, population-based cohort study of young Australian
women aged 18–23 years. The overall aim of this study was
to examine factors influencing contraceptive use and unin-
tended pregnancy among this cohort using three waves of
online self-report surveys conducted at six-monthly inter-
vals. Aspects of establishing the study and recruitment for
the online survey are outlined in detail elsewhere [23]. In
brief, women were recruited through media coverage,
attendance by the researcher team at face-to-face events,
social media (including paid Facebook advertising), Family
Planning clinics, and word of mouth. All women aged
between 18–23 years who were living in Australia at the
time of the survey were eligible to participate. The cohort
recruited was demographically representative of young
Australian women, with the exception of an over-
representation of high school completers [23]. The data
reported here are from the baseline survey.
Several open-ended, free-text questions were included
as part of the CUPID survey to allow for an expanded
understanding of women’s experiences. Analysis of
free-text comments from surveys can provide a deeper
understanding of survey topics, raise issues and reveal
conceptual relationships not previously considered
important by researchers [24, 25]. In this analysis we
examined women’s reports of the interactions they had
with a doctor about contraception from open-text re-
sponses to one general question about contraception
and pregnancy, located at the end of the survey: Is
there anything else you would like to tell us about
contraception (protection), your plans for pregnancy, or
your experience of pregnancy?
Data collection and analysis
Of the 3,795 participants in the survey, 1,038 (27.4%)
answered the open-ended question of interest. As the
focus of this article was to examine women’s reports of
interactions about contraception, data analysis began with
computer-assisted searches for occurrences of words that
indicated an interaction. That is, we extracted free-text
comments that contained one of the following words and
their derivatives: talk; told; tell(s) (ing); speak(s) (ing);
discuss(es) (ing) (ed); state(s) (d); mention(s) (ing) (ed);
ask(s) (ed) (ing); hear(d); suggest(s) (ing) (ed), and so
forth. We then examined the extracted comments in
order to seek understanding of the context within which
these terms were used, applying a combination of conven-
tional and summative content analysis techniques to com-
ments where women mentioned an interaction about
contraception with a doctor (the most commonly identi-
fied group). The extracted comments ranged in length
from a few words to multiple sentences.
Using qualitative content analysis methods allows re-
searchers to interpret the content of text data through
the systematic process of coding and identifying themes
[26]. Summative content analysis involves the identifica-
tion of key content followed by interpretation of the
underlying context, while conventional content analysis
involves the creation of an efficient number of coding
categories that represent similar meanings and are derived
directly from the text data [26]. We have integrated these
two approaches to content analysis because they align with
our research aim of capturing the participants’ unique per-
spectives without the imposition of preconceived categories
or theoretical perspectives.
Three of the authors (DG, CF, and JL) immersed
themselves with the data through reading the comments
extracted in the initial phase of analysis closely and re-
peatedly. They then highlighted words or sections of
the text that appeared to capture women’s meanings
within the context of talking with a doctor about
contraception, inductively generating coding categor-
ies. The unit of analysis was the portion of text in
which the woman described the interaction; typically
this was a brief portion of text, at most a sentence or
two. As this process continued, coding categories that
represented similar concepts were organised into
meaningful clusters, and labels that captured the key
theme/s of each cluster were developed by the first author.
To determine trustworthiness of the themes, a process of
reiterative feedback and discussion among all authors was
undertaken until consensus was reached.
Results
Of the 1,038 comments gathered by the final question in
the survey, 20.4% (n = 212) contained a term that flagged
a reported interaction. In comparison with the whole
cohort, a larger percentage of the women who answered
the final free-text question were engaged in full-time
study and living in urban areas. They were also more
likely to have finished secondary school, although not
more likely to have completed tertiary education. Table 1
compares the demographic information for all partici-
pants, those who answered the final question, and those
who reported on an interaction in their final answer.
Of the 212 women who reported an interaction about
contraception in their comments most (75%, n = 158)
mentioned talking to a doctor, 17% (n = 37) reported
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talking to their sexual partners, 9% (n = 20) to family mem-
bers, primarily mothers, 8% (n = 17) reported interactions
with friends, and 14% (n = 29) talked to someone else, for
example a pharmacist or teacher. Some women (n = 49) re-
ported speaking to more than one of these people.
The data presented here represent interactions that
women specifically had with doctors during consultations
about contraception, capturing overall themes related to
both the content and the process of such interactions.
These emergent themes and respective subthemes ex-
tracted from the data are presented in Table 2, and are
described in detail below alongside illustrative quotes from
participants. In presenting response extracts, we have
indicated the participant’s age and geographical location
(urban, regional, or remote1). Words that have been
omitted or inserted for contextual clarification are indi-
cated by an ellipsis or in roman script encircled by
square brackets, respectively.
Women’s perspectives on the content of contraceptive
discussions with doctors: what women want
When reporting on the content of patient-provider
interactions, young women overwhelmingly described
a desire for their doctor to present consistent and accurate
advice related to contraception, and highlighted their diffi-
culties in accessing such information at times. In some
cases women reported that they had received contradictory
information from different doctors, leading to frustration
and uncertainty about their contraception options:
I have had extreme difficulty finding a form of
contraception that works for me and am often told
conflicting things by different doctors. (21 year old
urban resident)
I usually see two different doctors to gain a second
opinion. It is unhelpful when they say several different
things and [are] essentially contradicting each other.
(22 year old urban resident)
Women similarly reported dissatisfaction around the
often limited contraception options that their doctor had
discussed with them, indicating that they would like to
have received more information about other eligible
options. In particular, our analysis suggested that- in
some cases- information regarding options other than
the contraceptive pill (‘the Pill’) was not provided by
doctors:
Often the Pill has been presented as the only option/
solution by doctors. I have done my own Internet
research about different types of contraceptives like the
arm implant [contraceptive implant2]. I wish I had
been given more information about this and other
options by a medical practitioner. (23 year old
regional resident)
I want the best for my body and don’t want to disrupt
it too much, and I have suggested [to doctors] in the
past that I want to use an alternative to the Pill (not
condoms either) and the doctors have not given me
options. (23 year old urban resident)
Furthermore, some women reported being exasperated
due to a perception that their doctor was limiting their
Table 1 Demographic characteristics of all CUPID participants










Total number 3795 (100%) 1038 (27.4%) 212 (20.4%)
Urban postcode 2415 (63.6%) 694 (66.9%) 158 (74.5%)
Median age (years) 20.7 20.8 20.9
Education
• Did not finish secondary
school
345 (9.1%) 88 (8.5%) 14 (6.6%)
• Graduated secondary
school
1673 (44.1%) 450 (43.4%) 98 (46.2%)
• Graduated tertiary
education
1692 (44.6%) 495 (47.7%) 95 (44.8%)
Work status
• Full time study 1831 (48.2%) 509 (49.0%) 122 (57.5%)
• Part time work 1734 (45.7%) 494 (47.6%) 98 (46.2%)
• Full time work 910 (24.0%) 237 (22.8%) 51 (24.1%)
Table 2 Overall themes and key findings extracted from the
data, N = 212
Theme Key findings
Women’s perspectives on
the content of contraceptive
discussions with doctors:
what women want
• Consistent and accurate
advice about contraception
• More information about
contraception options
• No discrimination based
on young age of the woman
• Comprehensive information
regarding the potential
side-effects of the chosen
method
• Specific consideration of
contraception options and
related issues for women
with complex medical profiles
(e.g. women with PCOS or
endometriosis)
Women’s perspectives on
the process of contraceptive
discussions with doctors: what
women experience
• Difficulties speaking to their
doctor about contraception,
due to e.g. their young age
and/or personal discomfort
• Perceptions of their doctor
as unsupportive or even
judgmental
Goldhammer et al. BMC Family Practice  (2017) 18:35 Page 4 of 10
contraceptive choices as an apparent reaction to their
(young) age. Some women thought that doctors per-
ceived them to be ineligible for certain contraception
methods owing to their age:
I feel that some doctors are biased [against] giving
young women longer-term contraceptive methods
(Mirena IUS3) due to their age and the idea that they
may want children soon…the Mirena IUS sounded like
a good option for me, but I had to try multiple type of
contraceptive pills before my doctor would agree to
insert it because it was considered a “last resort” for
women my age. (22 year old regional resident)
Women reported on the difficulties of obtaining com-
prehensive knowledge with respect to their chosen
contraception method, and in particular around gaining
an accurate understanding of the potential side-effects of
the method:
I was using Implanon2 and after two successful years I
began bleeding daily for about three months. I didn’t
know what was happening and my doctor couldn’t tell
me and just advised me to get a new one. Another
doctor told me later that it can 'wear off'. If this is the
case, people should be notified- most importantly
doctors, so they can advise correctly. Public knowledge
can only go so far; professionals need to keep up to
date. (22 year old urban resident)
I changed doctors (several years ago). My new doctor
informed me of how easily available the NuvaRing
[vaginal ring4] was - my last doctor never mentioned it
as an option and I was under the impression that it
was difficult to access in Australia at the time. Changing
doctors really changed the quality of my health regarding
contraception. (23 year old urban resident)
Specifically, the potential side-effects of a chosen
contraception method were highlighted by women as a
priority discussion point with their doctor, which report-
edly did not always occur- or else was not perceived as
satisfactorily thorough:
When I asked a doctor about the Implanon rod2, I
wasn't really given information. She just asked if I was
sure and gave me a script. I've had the rod for a few
months now, and whilst the convenience of not having
to worry about taking a pill every day is good, I wish I
had been told about the side-effects. I've had weight
gain, acne, mood swings and most annoyingly, month-long
periods. If I had been given this information, I would have
just stayed on the Pill or looked into another method.
(20 year old urban resident)
I wish there was more information on the adverse
reaction you can have with the Pill or hormonal
contraceptive and what other options I can take…any
information I can get on this subject would be more
than what I am currently receiving. (22 year old
urban resident)
Women with more complex medical profiles- such as
those experiencing polycystic ovarian syndrome (PCOS),
endometriosis, or a high body mass index (BMI)- similarly
highlighted the importance of discussing their contracep-
tive options with their doctor, emphasising the need to
talk about possible side-effects. Some also indicated that
their choice to use a particular contraceptive method was
not necessarily influenced by its reproductive action, but
rather by non-contraceptive benefits:
After having endometriosis and PCOS for years I think
doctors and nurses need to be more educated in what
contraceptive works for these issues. I've been
prescribed methods of contraceptive in the past that
have aggravated these symptoms. I also think they
need to be educated on the reasons why people go
on contraceptives; I've often felt as though I've been
put on one to stop pregnancy, when what I asked
and what I was looking for was help with my
endo[metriosis]/PCOS symptoms. (22 year old
regional resident)
I have taken the Pill for four years and have always
been overweight since first taking it. I was only told
last week that people with a BMI over 35 shouldn't
take the Pill because of an increased risk of blood
clots. I have seen at least four different doctors in that
time about filling my prescription for the Pill and none
of them mentioned this. I am clearly overweight.
Someone should have said something before now!
(22 year old regional resident)
Women’s perspectives on the process of contraceptive
discussions with doctors: what women experience
Women emphasised several aspects of the process of
interacting with doctors as impacting on their ability
and inclination to access contraception information via
this source. In particular, some of the young women in
this study reported that they found it difficult to speak
to their doctor regarding contraception. Reasons for
this varied between women and reflected both patient-
and provider-related barriers. Some women described
their youth as being an obstacle to comfortably having
or actively seeking out a discussion about contraception
with their doctor, while several reflected that personal
discomfort restricted this discussion:
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I find it really difficult to talk to doctors as I am young
and I feel that they don't think I take the information
that they give me on board. (23 year old urban resident)
I feel embarrassed to talk to the doctor about the side-
effects I am experiencing- no 23 year old should have no
sex drive. (23 year old urban resident)
I find the Pill is quite unhelpful in the sense [that]
when I take the brand I’m using, I find I’m very
moody, stress more, and find it hard to get motivated!
But I haven't spoken with any doctors about other
contraception, one because I don’t have time and two,
[because] I don’t feel too comfortable talking about
other methods- but I will try! (22 year old remote
resident)
Furthermore, some women perceived their doctor to
be unsupportive or even judgmental. Such perceptions
appeared to act as barriers to women reporting satisfactory
contraception consultations:
I have found that when visiting the doctor regarding
oral contraception, she was very abrupt and rude,
provided hardly any information, and was reluctant to
give me the prescription for the Pill. I have no medical
issues, so there was no reason to say no. I find this to
be quite rude and off-putting; many other people I
know experience this as well. I am not sure if this is a
cultural and age difference, but when going to the
doctor on issues which are important, I expect that I
am not treated in such a manner where I feel I am
judged based on my desire to protect myself from
pregnancy. (22 year old urban resident)
I find doctors can sometimes be shocked when I say I
don’t want to use hormonal contraception. They are
shocked and think that’s so irresponsible. But I’m 21-
I’m a grown woman. To me, the side-effects of the Pill
are so severe that I would personally rather take the
chance of an unplanned pregnancy with my partner of
two years than to continue to feel moody, depressed
and anxious, with terrible skin and lactating breasts.
There are so many judgments made by doctors about
your choices, which are unacceptable. (21 year old
urban resident)
Discussion
In this paper we examined the way that young women
aged 18 to 23 years reported on interactions with doctors
regarding contraception. Our analysis has suggested that
several aspects of the patient-provider interaction are rele-
vant for young Australian women accessing contraception,
with emergent themes indicating that both the content and
process of the contraception consultation are perceived by
women as being important. These findings have a
number of implications for clinical practice; in line
with the patient-centred model of care, we present
some recommendations below.
The desire to access comprehensive contraception-
related information and a wide(r) range of contraceptive
options through a doctor in order to be able to make an
informed choice about the method most suitable for the
individual was highlighted by the women’s narratives.
This echoes themes emerging from a previous analysis
of free-text comments from the Australian Longitudinal
Study on Women’s Health (ALSWH), within which
Australian women reported difficulties accessing infor-
mation about contraception and barriers to method
access [22]. Previous studies have demonstrated that a
large proportion of women possess poor knowledge of
contraception options [27, 28], in particular highly ef-
fective LARC methods [29], which acts as a barrier to
their use- suggesting that doctors can play an active
role in increasing (young) women’s awareness of contra-
ceptive options. Indeed, in one recent study, participants
articulated that knowledge about contraceptive options
was seen by doctors as ‘assumed knowledge’ that women
should possess [30], and a number of researchers have
found that doctors do not comprehensively discuss
contraceptive options with their patients [31, 32].
Acknowledging the time constraints faced by doctors
in general practice settings [33], the utilisation of credible
websites and/or decision-making tools for women may act
as important adjuncts to the consultation proper. Such
resources may enhance a woman’s understanding of
evidence-based information to support her contracep-
tive choices, with the role of the doctor then being to
determine her medical suitability for a particular
method and to provide information about possible
side-effects and their management within the consult-
ation time. It also appears imperative to introduce
more comprehensive education about contraception
methods and options within health and physical educa-
tion curricula in Australian schools, particularly if doc-
tors are automatically assuming that women possess
such knowledge [30].
Women in our study expressed a desire for consistent
and accurate advice from their doctors, and reported
frustrations upon encountering contradictory information,
which led to uncertainty about their method options. Fur-
thermore, women perceived their choice of method was re-
stricted by their doctor, through the discussion of a limited
number of options within the consultation time. Some
women also expressed the belief that their young age was a
factor biasing the method options discussed. This resonates
with previous research, which found that providers hold
biases with respect to the suitability of young and/or
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nulliparous women using certain contraceptive methods
[31, 34, 35]. It is also recommended that doctors keep
abreast of developments in contraceptive technology,
access up-to-date guidelines with respect to the suitability
for use and method contraindications for particular sub-
sets of women, and refrain from making assumptions re-
garding the reasons that individual women are seeking
contraception.
As described by some of our participants, contraceptive
method choice may be influenced by non-contraceptive
benefits; a finding comparable to data emerging from the
Bettering the Evaluation and Care of Health (BEACH)
program, which collected information about the clinical
activities in general practice in Australia over an 18 year
period [36]. These data suggest that over a quarter of
contraceptive prescriptions for young women are made
for non-contraceptive purposes, such as a treatment for
acne or menstrual problems. In order for women to truly
experience reproductive autonomy and control it is
necessary that the contraceptive consultation be struc-
tured around a woman’s priorities, whether this be
method effectiveness and/or other considerations [37].
Indeed, the contraceptive consultation is most effective
when women’s concerns are understood by the health-
care provider [20].
A recent committee opinion by the American College
of Obstetricians and Gynecologists recommends that
doctors adopt a shared decision-making approach within
the contraception consultation in order to optimise contra-
ceptive choice [38]. That is, doctors should endeavour to
take into account a woman’s unique circumstances and
enquire as to the woman’s particular needs, preferences,
expectations, and reproductive goals to ensure that
advice is tailored appropriately [39]. Adopting such pa-
tient-centred, shared decision-making strategies could
counteract the perception of some of our participants that
their doctor was unsupportive or judgmental during the
contraceptive consultation, which has previously been de-
scribed by other studies conducted within both Australia
[22] and overseas [21].
Women in our study emphasised the importance of
discussing the possible side-effects of contraceptive
methods with their doctor and voiced frustrations that
they were not provided with (comprehensive) informa-
tion about these. Discussing side-effects may be particu-
larly relevant in women’s decision-making, with women
consistently ranking side-effects among the three most
important factors influencing their contraceptive choice
[40]. Furthermore, the impact of side-effects on both
physical and mental health has a considerable influence
on a woman’s willingness to use or continue using cer-
tain methods [22, 41, 42]. Nevertheless, it has been dem-
onstrated that effective pre-use discussion of side-effects
can reduce discontinuation rates even if the woman
experiences side-effects [43], and practitioners recognise
the importance of providing more and better coun-
selling in order to improve patient’s contraceptive
use [44].
It is not merely the content but also the process of the
contraception consultation that women perceived as
important within our study. Some women reported diffi-
culties discussing contraception-related topics with their
doctor, attributing these difficulties to their young age,
personal discomfort, and embarrassment with experiences
of particular side-effects. Similar barriers have been re-
ported in prior literature, with providers in one study
reflecting that patients often exhibit discomfort talking
about contraception [45]. Nonetheless, providers in that
study also held the belief that patients should be the ones
to initiate discussions about contraception. Given the dis-
comfort reported by some women in our study, providers
need to be aware that some women will find discussions
about contraception uncomfortable and they may therefore
need to employ a variety of communication strategies to
support the woman in feeling comfortable to discuss sensi-
tive contraception-related issues. Conducting an effective
contraceptive consultation requires a combination of
medical knowledge and communication skills, highlight-
ing the need for doctors to receive good communication
skills training and empower their patients to ask questions
[39, 46].
In making these recommendations, we acknowledge
the need to involve other health care providers, other than
doctors, in educating, informing, and assisting women to
make the best contraceptive choice for themselves. It is well
within the scope of expertise of multidisciplinary healthcare
providers to provide such information. Therefore, we
propose a strategy to contraception provision that utilises
other healthcare providers such as practice nurses, nurse
practitioners, and pharmacists, so that the time-intensive
nature of providing comprehensive contraception infor-
mation can be shared. Another consideration may be to
increase the capacity of practice nurses such that they are
able to prescribe contraception as takes place in specialist
sexual health services in the UK [47], for which there is
current advocacy in Australia [48]. The scope is also
expanding to include insertion of contraceptive implants
and intrauterine devices (IUDs) [49]. Increasing access to
contraceptive services in primary care, and professional
education about contraception might also fill this gap in
service provision.
There are very little data on the way in which doc-
tors inform or advise women, and therefore affect
decisions to start, continue, or cease a contraceptive
method [12]. The gap between what (young) women
want and what they experience when talking to their
doctors about contraception will require further ex-
ploration in future studies.
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Study strengths, limitations, and suggestions for future
research
The large number of responses that were available for
analysis represents one of the strengths of this qualitative
study and has enabled us to identify numerous aspects of
the contraceptive consultation that are important for young
women. Responses were provided by women responding to
a general question about contraception in the context of a
larger health survey, with women not specifically directed
to consider the interactions that they had with their doctor
nor their perception of contraceptive consultations; yet
over 15% of women who answered the question felt
that these were important enough to mention, giving
weight to our data.
It must be acknowledged that the phrasing of the
question- and indeed the focus of the survey in general-
shaped the data collected, with participants possibly
having been primed by the earlier questions to focus on
particular aspects of their contraceptive experiences. As
appears to be the nature of this kind of research, women
who had problems with contraception were more likely
to have wanted to write about it [25]; therefore, the
overriding tone of the data presented here were reports
of negative experiences. While it needs to be acknowl-
edged that women were more likely to recall and recount
negative experiences, it is nonetheless important to repre-
sent such occurrences and attempt to understand the rea-
sons for them. It may be that using a direct approach to
enquire about a woman’s interactions within contraceptive
consultations would allow for a more balanced account to
emerge, and clarification around points of interest (which
was not possible in the current study) could be enhanced
through utilising an interview format.
Free-text comments are increasingly recognised as a
valid and rich source of data [50]. It is likely that the
women wrote about their most salient and important
experiences relating to contraception. Of course, this
analysis was only able to capture such salient aspects of
the contraceptive consultation from a woman’s perspec-
tive; in order to gain a comprehensive picture of what
occurs in the contraceptive consultation, future research
should also consider the contraceptive consultation from
a practitioner’s viewpoint.
Conclusions
This exploration has revealed the salient health com-
munication issues for young Australian women when
discussing contraception with doctors. Within the
context of a contraception consultation, young women
perceive both the content and process of the patient-
provider interaction to be important. The data pre-
sented here provide a deeper understanding of how
such consultations may be more constructively con-
ducted within the framework of patient-centred care,
with the recommendation for doctors to adopt shared
decision-making strategies within practice. It is im-
portant for all women to have comprehensive contra-
ceptive options presented to them and be supported in
making choices about contraception that suit their
individual circumstances.
Endnotes
1Geographical location is defined here in accordance
to the Australian Statistical Geography Standard [51].
2A contraceptive implant is a rod-shaped etonogestrel-
releasing implant that is inserted subdermally in the
upper inner arm to prevent pregnancy for up to three
years. Tradenames: Implanon/Implanon NXT.
3A hormonal intrauterine device (IUD), also known as
an intrauterine system (IUS), is a T-shaped levonorgestrel-
releasing device placed in the uterus to prevent pregnancy
for up to five years. Tradename: Mirena.
4A vaginal ring is an etonogestrel/ethinyl estradiol-
releasing ring that is placed in the vagina for three weeks
then replaced with a new one a week later. Tradename:
NuvaRing.
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